Use of Critical Pathways to Improve Efficiency: A Cautionary TaleBySanjay Saint, MD, MPH,Timothy P. Hofer, MD, MSc,Judith S. Rose, MS,Samuel R. Kaufman, MA,Laurence F. McMahon Jr, MD, MPHNovember 1st 2003
Correspondence Regarding, "Validation of Data Collection for the HEDIS Performance Measure on Chlamydia Screening in a MCO"BySarah Hudson Scholle, MPH, DrPH,Lok Wong, MHS,Joachim Roski, PhD, MPHNovember 1st 2003
Prescribing COX-2s for Patients New to Cyclo-oxygenase Inhibition TherapyByEmily R. Cox, PhD,Brenda Motheral, PhD,Mark Frisse, MD*,Andrew Behm, PharmD,Doug Mager, BSNovember 1st 2003
Chronic Obstructive Pulmonary Disease: The Impact Occurs Earlier Than We ThinkByDavid Tinkelman, MD,Philip Corsello, MDNovember 1st 2003
Mechanisms to Improve Pharmaceutical Use in Managed Care: To Study Controls, Control the Studies [Please]ByA. Mark Fendrick, MDNovember 1st 2003
Changing Medication Use in Managed Care: A Critical Review of the Available EvidenceBySallie-Anne Pearson, PhD,Dennis Ross-Degnan, ScD,Ann Payson, MA,Stephen B. Soumerai, ScDNovember 1st 2003
Implementation of Systems Strategies for Breast and Cervical Cancer Screening Services in Health Maintenance OrganizationsByKarin Valentine Goins, MPH,Jane G. Zapka, ScD,Ann M. Geiger, PhD,Leif I. Solberg, MD,Stephen Taplin, MD,Marianne Ulcickas Yood, DSc,JoNovember 1st 2003